Josh F. Peterson, MD, MPH, is a Professor of Biomedical Informatics and Medicine in the School of Medicine at Vanderbilt University Medical Center and he is a Fellow of the American College of Medical Informatics. Dr. Peterson received his M.D. through the Vanderbilt University School of Medicine (VUMC) in 1997 and completed an Internal Medicine residency at Duke University Medical Center, a fellowship in General Internal Medicine at the Brigham and Women’s Hospital, and a Master of Public Health degree at the Harvard School of Public Health. Dr. Peterson’s research interests are in precision medicine with a focus on developing systems of care to improve drug safety and efficacy and the translation of genomic technologies to routine practice. He serves as the Vice-President for Personalized Medicine and the Director for the Center for Precision Medicine at VUMC where he develops systems of care to translate genomic technologies to routine practice. He currently serves as a principal investigator for RISE, an NIH-funded project to simulate the clinical impact and cost-effectiveness of performing sequencing across large populations over their lifetime. He is also active within a variety of NHGRI sponsored research consortia, including eMERGE where he leads the Coordinating Center, and IGNITE Network where he is principal investigator of the I3P Clinical Site and serves as Network Chair. In these capacities, he is conducting cohort studies and randomized clinical trials to test novel genomic medicine interventions. Dr. Peterson was also the founding Program Director for the Master of Applied Clinical Informatics (MSACI) which trains physicians and other health professionals in the field of Clinical Informatics, and currently serves as Program Director for the Vanderbilt Genomic Medicine training program. 

PUBLICATIONS

Eric R. Gamazon, PhD, MS is a tenured member of the faculty of the Division of Genetic Medicine at Vanderbilt University Medical Center. He is a Life Member of Clare Hall, University of Cambridge.

He is interested in what can be learned from DNA sequence and multi-omics data about disease mechanism, therapeutic intervention, molecular evolution, and genome function. An ongoing project involves understanding the effect of genetic variation on gene regulation across tissues and cell types to gain insights into disease mechanisms and therapeutic targets. He utilizes large-scale DNA biobank data linked to electronic health records, along with data science and computation, to identify genes involved in human health and disease in diverse populations, to discover novel biomarkers, and to enable a comprehensive systems view of the disease phenome.

His laboratory is an interdisciplinary group with expertise in computational genomics and molecular biology. The lab has been the research training ground for a Barry Goldwater Scholar, a Fulbright Scholar, and a NARSAD Young Investigator Grant recipient. See https://my.vanderbilt.edu/ericgamazon/ for more information. 

He co-chaired the GWAS Working Group of the GTEx Consortium and has served on various National Institutes of Health (NIH) study sections. He was a recipient (2019) of the inaugural Genomic Innovator Award from the NIH.